AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 127.04 No Change ▼ 0.00 (0%)
BOP 6.67 No Change ▼ 0.00 (0%)
CNERGY 4.51 No Change ▼ 0.00 (0%)
DCL 8.55 No Change ▼ 0.00 (0%)
DFML 41.44 No Change ▼ 0.00 (0%)
DGKC 86.85 No Change ▼ 0.00 (0%)
FCCL 32.28 No Change ▼ 0.00 (0%)
FFBL 64.80 No Change ▼ 0.00 (0%)
FFL 10.25 No Change ▼ 0.00 (0%)
HUBC 109.57 No Change ▼ 0.00 (0%)
HUMNL 14.68 No Change ▼ 0.00 (0%)
KEL 5.05 No Change ▼ 0.00 (0%)
KOSM 7.46 No Change ▼ 0.00 (0%)
MLCF 41.38 No Change ▼ 0.00 (0%)
NBP 60.41 No Change ▼ 0.00 (0%)
OGDC 190.10 No Change ▼ 0.00 (0%)
PAEL 27.83 No Change ▼ 0.00 (0%)
PIBTL 7.83 No Change ▼ 0.00 (0%)
PPL 150.06 No Change ▼ 0.00 (0%)
PRL 26.88 No Change ▼ 0.00 (0%)
PTC 16.07 No Change ▼ 0.00 (0%)
SEARL 86.00 No Change ▼ 0.00 (0%)
TELE 7.71 No Change ▼ 0.00 (0%)
TOMCL 35.41 No Change ▼ 0.00 (0%)
TPLP 8.12 No Change ▼ 0.00 (0%)
TREET 16.41 No Change ▼ 0.00 (0%)
TRG 53.29 No Change ▼ 0.00 (0%)
UNITY 26.16 No Change ▼ 0.00 (0%)
WTL 1.26 No Change ▼ 0.00 (0%)
BR100 10,010 Increased By 126.5 (1.28%)
BR30 31,023 Increased By 422.5 (1.38%)
KSE100 94,192 Increased By 836.5 (0.9%)
KSE30 29,201 Increased By 270.2 (0.93%)

A small molecule derived from an Asian herb may help stop Ebola infection by preventing the virus from entering the cells of the body, researchers said on February 26. So far the research using the calcium channel blocker Tetrandrine, found in some Chinese and Japanese herbs, against Ebola has only been done in lab animals.
However, the findings so far warrant tests in primates before possibly being tried in people, said the authors of the study in the journal Science.
Researchers studied several existing drugs currently used to treat high blood pressure in order to find out which small molecules were best at blocking the Ebola virus from moving any further through the cell.
Tetrandrine protected mice from disease without obvious side effects, and appeared to be the most potent of the compounds tested.
"When we tested in mice, the drugs stopped virus replication and saved most of them from disease," said Robert Davey, scientist and Ewing Halsell Scholar in the Department of Immunology and Virology at Texas Biomedical Research Institute.
"We are very excited about the progress made in this study and the momentum it provides as scientists across the world vigorously search for effective vaccines and treatments against Ebola virus," Davey said. There is no drug on the market to treat Ebola, which has killed more than 9,000 people, mainly in West Africa, since 2013 in the world's largest outbreak to date.
"We are cautiously optimistic. The next step in the process is to test both safety and effectiveness of the interaction of the drug with Ebola virus in non-human primates," said Davey.
Co-authors on the research came from the University of Texas Medical Branch at Galveston; the Center for Integrated Protein Science Munich (CIPSM) at Ludwig-Maximilians - Universitat München in Munich, Germany and the Southwest Research Institute in San Antonio, Texas.

Copyright Agence France-Presse, 2015

Comments

Comments are closed.